Skip to content

De La Torre Javier

  • Facultativo
  • Hospital Costa del Sol
  • 17h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 866CitationsNumber of citations received by De La Torre's publications. Updated daily.

Research interests

Infectious diseasesInternal medicineHIV

Co-authors (1560)

Publications (5)

  • Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

    • Hofstra L
    • Sauvageot N
    • Albert J
    • et al.
    N/AReaders
    39Citations
    Get full text
  • Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    • Perez-Molina J
    • Rubio R
    • Rivero A
    • et al.
    N/AReaders
    54Citations
    Get full text
  • Primary resistance to integrase strand-transfer inhibitors in Europe

    • Casadell? M
    • van Ham P
    • Noguera-Julian M
    • et al.
    N/AReaders
    21Citations
    Get full text
  • Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

    • Frentz D
    • Van de Vijver D
    • Abecasis A
    • et al.
    N/AReaders
    21Citations
    Get full text
  • Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    • Berenguer J
    • Gonz?lez J
    • Ribera E
    • et al.
    N/AReaders
    26Citations
    Get full text

Professional experience

Facultativo

Hospital Costa del Sol

June 1993 - Present